These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 19846871)

  • 1. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
    Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
    J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
    Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.
    Satoh-Takayama N; Lesjean-Pottier S; Sawa S; Vosshenrich CA; Eberl G; Di Santo JP
    Eur J Immunol; 2011 Mar; 41(3):780-6. PubMed ID: 21341264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.
    Satoh-Takayama N; Lesjean-Pottier S; Vieira P; Sawa S; Eberl G; Vosshenrich CA; Di Santo JP
    J Exp Med; 2010 Feb; 207(2):273-80. PubMed ID: 20142427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
    Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
    J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
    Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
    J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of NK cells and NK-like cells from the intestinal lamina propria.
    Sanos SL; Diefenbach A
    Methods Mol Biol; 2010; 612():505-17. PubMed ID: 20033661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
    Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
    J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen.
    Reid-Yu SA; Small CL; Coombes BK
    Eur J Immunol; 2013 Oct; 43(10):2638-49. PubMed ID: 23775576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.
    Zheng Y; Valdez PA; Danilenko DM; Hu Y; Sa SM; Gong Q; Abbas AR; Modrusan Z; Ghilardi N; de Sauvage FJ; Ouyang W
    Nat Med; 2008 Mar; 14(3):282-9. PubMed ID: 18264109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.
    Merzoug LB; Marie S; Satoh-Takayama N; Lesjean S; Albanesi M; Luche H; Fehling HJ; Di Santo JP; Vosshenrich CA
    Eur J Immunol; 2014 Nov; 44(11):3380-91. PubMed ID: 25142413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-22 producing NKp46+ innate lymphoid cells can differentiate from hematopoietic precursor cells.
    Kim MS; Kim WS; Piao ZH; Yun S; Lee SH; Lee S; Jeong M; Sun HN; Park YJ; Jung H; Yoon SR; Choi I
    Immunol Lett; 2011 Dec; 141(1):61-7. PubMed ID: 21835206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.
    Narni-Mancinelli E; Jaeger BN; Bernat C; Fenis A; Kung S; De Gassart A; Mahmood S; Gut M; Heath SC; Estellé J; Bertosio E; Vely F; Gastinel LN; Beutler B; Malissen B; Malissen M; Gut IG; Vivier E; Ugolini S
    Science; 2012 Jan; 335(6066):344-8. PubMed ID: 22267813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression.
    Rossi LE; Avila DE; Spallanzani RG; Ziblat A; Fuertes MB; Lapyckyj L; Croci DO; Rabinovich GA; Domaica CI; Zwirner NW
    J Leukoc Biol; 2012 Feb; 91(2):321-31. PubMed ID: 22124136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression.
    Kim HR; Chwae YJ; Kim J
    Scand J Immunol; 2010 Jun; 71(6):413-9. PubMed ID: 20500693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
    Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 and its activators in intestinal defense and mucosal homeostasis.
    Hruz P; Dann SM; Eckmann L
    Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.